| scholarly article | Q13442814 |
| P50 | author | Renate B. Schnabel | Q21264509 |
| Stefan Blankenberg | Q28039327 | ||
| Veikko Salomaa | Q28050067 | ||
| Tanja Zeller | Q29840607 | ||
| Kari Kuulasmaa | Q30428761 | ||
| Maria F Hughes | Q58811708 | ||
| Frank Kee | Q89750885 | ||
| Tarja Tuovinen | Q114334757 | ||
| P2093 | author name string | Olli Saarela | |
| Mark Woodward | |||
| Allan Struthers | |||
| Hugh Tunstall-Pedoe | |||
| Francisco Ojeda | |||
| MORGAM Investigators | |||
| P2860 | cites work | A Sensitive Cardiac Troponin T Assay in Stable Coronary Artery Disease | Q29028464 |
| Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond | Q29614697 | ||
| Time-dependent ROC curves for censored survival data and a diagnostic marker | Q30600327 | ||
| Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study | Q34768805 | ||
| Sensitive cardiac troponin T assay and the risk of incident cardiovascular disease in women with and without diabetes mellitus: the Women's Health Study | Q35130613 | ||
| Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC) | Q35773156 | ||
| MORGAM (an international pooling of cardiovascular cohorts). | Q35961881 | ||
| Comparison of the prediction by 27 different factors of coronary heart disease and death in men and women of the Scottish Heart Health Study: cohort study | Q36246409 | ||
| Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. | Q36574151 | ||
| Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: the MONICA, risk, genetics, archiving, and monograph (MORGAM) biomarker project | Q38416428 | ||
| Distribution and categorization of left ventricular measurements in the general population: results from the population-based Gutenberg Heart Study | Q39855343 | ||
| Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population | Q41666469 | ||
| Early diagnosis of myocardial infarction with sensitive cardiac troponin assays | Q43285257 | ||
| Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease | Q48161023 | ||
| Improving the primary prevention of cardiovascular events by using biomarkers to identify individuals with silent heart disease | Q48399263 | ||
| Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction. | Q50982435 | ||
| Defining high-sensitivity cardiac troponin concentrations in the community. | Q51064876 | ||
| How would the Reverend Bayes interpret high-sensitivity troponin? | Q51717340 | ||
| P433 | issue | 5 | |
| P921 | main subject | circulatory system | Q11068 |
| biomarker | Q864574 | ||
| P304 | page(s) | 271-281 | |
| P577 | publication date | 2013-10-08 | |
| P1433 | published in | European Heart Journal | Q2286839 |
| P1476 | title | High population prevalence of cardiac troponin I measured by a high-sensitivity assay and cardiovascular risk estimation: the MORGAM Biomarker Project Scottish Cohort | |
| P478 | volume | 35 |
| Q55452820 | A practical approach for the validation and clinical implementation of a high-sensitivity cardiac troponin I assay across a North American city. |
| Q55021882 | Adjusted Troponin I for Improved Evaluation of Patients with Chest Pain. |
| Q38601283 | Anti-cardiac troponin antibodies in clinical human disease: a systematic review |
| Q33555770 | Asia-Pacific consensus statement on the optimal use of high-sensitivity troponin assays in acute coronary syndromes diagnosis: focus on hs-TnI. |
| Q38649620 | Association Between High-Sensitivity Cardiac Troponin I and Cardiac Events in Elderly Women |
| Q40279611 | Association Between High-Sensitivity Cardiac Troponin Levels and Myocardial Ischemia During Mental Stress and Conventional Stress. |
| Q86836389 | Association of high-sensitivity assayed troponin I with cardiovascular phenotypes in the general population: the population-based Gutenberg health study |
| Q53769393 | Be more sensitive, please - using cardiac troponin assays for diagnosing AMI. |
| Q39215627 | Biomarker-based risk prediction in the community |
| Q54624187 | Biomarkers in the triage of chest pain: are we making progress? |
| Q35025720 | Biomarkers of cardiovascular disease risk in women |
| Q57161306 | Cardiac Troponin I and Cardiovascular Risk in Patients With Chronic Obstructive Pulmonary Disease |
| Q38543356 | Cardiovascular biomarkers and sex: the case for women |
| Q48178771 | Cardiovascular risk prediction: Can Systematic Coronary Risk Evaluation (SCORE) be improved by adding simple risk markers? Results from the Copenhagen City Heart Study |
| Q92465933 | Clinical determinants of plasma cardiac biomarkers in patients with stable chest pain |
| Q38762394 | Combination of high-sensitivity troponin I and N-terminal pro-B-type natriuretic peptide predicts future hospital admission for heart failure in high-risk hypertensive patients with preserved left ventricular ejection fraction |
| Q35110759 | Comparison of three troponins as predictors of future cardiovascular events--prospective results from the FINRISK and BiomaCaRE studies |
| Q47613575 | Discrimination of patients with type 2 myocardial infarction |
| Q47858742 | Distribution of cardiac troponin I in the Japanese general population and factors influencing its concentrations. |
| Q47341126 | Effect of weight loss on subclinical myocardial injury: A clinical trial comparing gastric bypass surgery and intensive lifestyle intervention |
| Q48617743 | Effects of renal denervation on heart failure biomarkers and blood pressure in patients with resistant hypertension |
| Q36316630 | Elevated plasma levels of cardiac troponin-I predict left ventricular systolic dysfunction in patients with myotonic dystrophy type 1: A multicentre cohort follow-up study |
| Q30251632 | Epidemiology of cardiovascular disease: recent novel outlooks on risk factors and clinical approaches |
| Q40617829 | Factors independently associated with cardiac troponin I levels in young and healthy adults from the general population |
| Q38657042 | High-Sensitivity Cardiac Troponin Concentration and Risk of First-Ever Cardiovascular Outcomes in 154,052 Participants |
| Q61727650 | High-Sensitivity Cardiac Troponin I and the Diagnosis of Coronary Artery Disease in Patients With Suspected Angina Pectoris |
| Q37524838 | High-Sensitivity Cardiac Troponin, Statin Therapy, and Risk of Coronary Heart Disease |
| Q54968744 | High-Sensitivity Troponin I Levels and Coronary Artery Disease Severity, Progression, and Long-Term Outcomes. |
| Q93053477 | High-Sensitivity Troponin and the Application of Risk Stratification Thresholds in Patients With Suspected Acute Coronary Syndrome |
| Q35648924 | High-sensitivity cardiac troponin I and B-type natriuretic Peptide as predictors of vascular events in primary prevention: impact of statin therapy |
| Q40825589 | High-sensitivity cardiac troponin I and incident coronary heart disease among asymptomatic older adults |
| Q41445591 | High-sensitivity detection of cardiac troponin I with UV LED excitation for use in point-of-care immunoassay. |
| Q36407050 | High-sensitivity troponin I and amino-terminal pro--B-type natriuretic peptide predict heart failure and mortality in the general population |
| Q38262571 | High-sensitivity troponin: where are we now and where do we go from here? |
| Q40347012 | Higher prevalence of detectable troponin I among cocaine-users without known cardiovascular disease |
| Q55265544 | Increased Levels of Cardiac Troponin I in Subjects with Extremely Low B-type Natriuretic Peptide Levels. |
| Q38192517 | Making sense of high sensitivity troponin assays and their role in clinical care |
| Q38586900 | New and emerging biomarkers in cardiovascular disease |
| Q38216483 | New risk markers for cardiovascular prevention |
| Q38613760 | Novel biomarkers for cardiovascular risk assessment: current status and future directions |
| Q36472407 | Prediction of Cardiovascular Disease Risk by Cardiac Biomarkers in 2 United Kingdom Cohort Studies: Does Utility Depend on Risk Thresholds For Treatment? |
| Q36376682 | Prime mover or fellow traveller: 25-hydroxy vitamin D's seasonal variation, cardiovascular disease and death in the Scottish Heart Health Extended Cohort (SHHEC) |
| Q36235438 | Prognostic value of basal high-sensitive cardiac troponin levels on mortality in the general population: A meta-analysis |
| Q52662453 | Relations of Sex to Diagnosis and Outcomes in Acute Coronary Syndrome. |
| Q46193259 | Relationship between high-sensitivity cardiac troponin I and blood pressure among young and healthy adults |
| Q92687695 | Repeat Measurements of High Sensitivity Troponins for the Prediction of Recurrent Cardiovascular Events in Patients With Established Coronary Heart Disease: An Analysis From the KAROLA Study |
| Q39150426 | ST2 may not be a useful predictor for incident cardiovascular events, heart failure and mortality |
| Q55313415 | Sensitive Troponin I Assay in Patients with Chest Pain - Association with Significant Coronary Lesions with or Without Renal Failure. |
| Q27027899 | State of the Art: Newer biomarkers in heart failure |
| Q36376112 | The effect of exercise training on the course of cardiac troponin T and I levels: three independent training studies. |
| Q28072221 | The year in cardiology 2015: prevention |
| Q37170644 | Troponin I and cardiovascular risk prediction in the general population: the BiomarCaRE consortium |
| Q38734398 | Troponin in Cardiovascular Disease Prevention: Updates and Future Direction |
| Q58604607 | Use of High-Sensitivity Cardiac Troponin for the Exclusion of Inducible Myocardial Ischemia: A Cohort Study |
| Q36181627 | Which biomarkers are predictive specifically for cardiovascular or for non-cardiovascular mortality in men? Evidence from the Caerphilly Prospective Study (CaPS). |
Search more.